This inventor holds 1 USPTO granted patent. Top assignee: Bayer Aktiengesellschaft. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Christoph Philipp Hethey: Inventor of SOS1 Inhibitor Compounds.
Introduction
Christoph Philipp Hethey is an inventor based in Berlin, Germany, associated with Bayer Aktiengesellschaft. His work includes a patent concerning phosphorus derivatives developed as SOS1 inhibitors.
Latest Patents
Hethey is credited with 1 patent: “Phosphorus Derivatives as SOS1 Inhibitors.” The invention covers phosphorus derivatives, methods for preparing them, useful intermediate compounds, and pharmaceutical compositions and combinations containing them. It also describes using these compounds to manufacture medicines for treating or preventing diseases, particularly hyperproliferative disorders associated with SOS1, either alone or alongside other active ingredients.
Career Highlights
Hethey’s listed patent work is connected to pharmaceutical research at Bayer Aktiengesellschaft. The patent focuses on compounds and potential therapeutic applications involving SOS1.
Collaborations
Felix Pape and Benjamin Bader are identified as Hethey’s coworkers.
Conclusion
Christoph Philipp Hethey’s patent contribution centers on phosphorus-based SOS1 inhibitors and their potential use in pharmaceutical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
